Home
TOP INDUSTRY NEWS
-
J&J Completes $14.6-Bn Acquisition of Intra-Cellular Therapeutics
-
Lonza Initiates New Organizational Structure
-
Supplier News: SHL, Resilience, AGC Biologics, Incog BioPharma & More
-
Global Briefs: Novo Nordisk, Bharat Biotech & More
-
J&J Announces $55-Bn in US Investments; Breaks Ground on $2-Bn Biologics Mfg Facility
-
Merck & Co. Opens $1-Bn Vaccine Mfg Facility
Features
-
CEOs, Senior Executives Highlight Mfg Expansions at the DCAT Member Company Announcement Forum
CEOs and senior executives from DCAT Member Companies highlighted their companies’ major news at the DCAT Member Company Announcement Forum at DCAT Week. Manufacturing expansions for peptides, biomanufacturing, and sterile manufacturing led the news.
-
DCAT Value Chain Insights Bonus Coverage: From DCAT Week 2025 Member Company News Roundup
What other DCAT Member Companies are making the news? A roundup of the latest developments from CDMOs/CMOs and other suppliers in active pharmaceutical ingredients (small molecules and biologics) to drug products (solid dosage, injectables and specialty dosage forms), and packaging.
-
SPONSORED CONTENT
Latest Investments in High Containment Confirm Indena’s Excellence in CDMO Services
-
SPONSORED CONTENT
Overcoming Barriers To Patient Adherence With A Novel Dosage Form
-
SPONSORED CONTENT
OLON GROUP ANNOUNCES THE ACQUISITION OF GTP BIOWAYS GROUP
DCAT MEMBER COMPANY COMMUNITY
-
ESG Update: DCAT Member Companies in the Community
The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement…
-
New Member Company Alert
Welcome to our Newest Member Companies! We are pleased to welcome the following companies to our DCAT Member Community. To View all DCAT member companies visit the Member Directory. From…
-
New! ESG Update: DCAT Member Companies in the Community
The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement…
-
New! Production to Prescription Podcast: Parenteral Drug Manufacturing—CDMO Outlook: A Capacity Crunch or Easing?
What will be the key issues in the CDMO space for parenteral drug manufacturing in 2025? The latest episode of DCAT Value Chain Insights’ original podcast Production to Prescription, examines…
